A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 1, 1997, Pages 176-181

  Newell Price, John ^a   Perry, Les ^a   Medbak, Sami ^a   Monson, John ^a   Savage, Martin ^a   Besser, Michael ^a   Grossman, Ashley ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DESMOPRESSIN; HYDROCORTISONE; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CORTICOTROPIN TEST; CUSHING DISEASE; CUSHING SYNDROME; DOSE RESPONSE; FEMALE; FLUSHING; HUMAN; HYDROCORTISONE RELEASE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINUS TACHYCARDIA; TASTE DISORDER;

ACTH SYNDROME, ECTOPIC; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CHILD; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; DEAMINO ARGININE VASOPRESSIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PITUITARY NEOPLASMS;

EID: 0031014028     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.1.176     Document Type: Article

References (30)

1. Grossman A, Kruseman AC, Perry L, et al. 1982 New hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotrophic hormone and cortisol in man. Lancet. 1:921-922.
2. Orth DN, DeBold CR, Decherney GS, et al. 1982 Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab. 55:1017-1019.
3. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler Jr GB, Loriaux DL. 1984 The corticotropin-releasing factor test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med. 310:622-626.
4. Trainer PJ, Grossman A. 1991 The diagnosis and differential diagnosis of Cushing's syndrome [Review]. Clin Endocrinol (Oxf). 34:317-330.
5. Orth DN. 1992 Corticotropin-releasing hormone in humans. Endocr Rev. 13:164-191.
6. Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW. 1986 The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Lancet. 2:540-544.
7. Nieman LK, Chrousos GP, Oldfield EH, Averingos PC, Cutler Jr GB, Loriaux DL. 1986 The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med. 105:862-867.
8. Grossman AB, Hewlett TA, Perry L, et al. 1988 CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol (Oxf). 29:540-544.
9. DeBold CR, Sheldon WR, DeCherney GS, et al. 1984 AVP potentiates ACTH release induced by ovine CRF. J Clin Invest. 73:533-538.
10. 3 pituitary vasopressin receptor. FEBS Lett. 356:215-220.
11. 1b vasopressin receptor J Biol Chem. 269:27088-27092.
12. Catania A, Cantalamessa L, Orsatti A, et al. 1984 Plasma ACTH-response to the corticotropin-releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test. Metabolism. 33:478-481.
13. Taberin A, San Gailli F, Dezou S, et al. 1990 The corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: a comparison with the lysine vasopressin test. Acta Endocrinol (Copenh). 123:331-338.
14. Bertagna X, Coste J, Raux-Demay MC, Letrait M, Strauch G. 1994 The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype. J Clin Endocrinol Metab. 79:390-394.
15. Edwards CRW, Kitau MJ, Chard T, Besser GM. 1973 Vasopressin anal DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J. 579:375-378.
16. Sawyer WH, Acosta M, Balaspiri L, Judd J, Manning M. 1974 Structural changes in the arginine vasopressin molecule. Endocrinology. 94:1106-1115.
17. Gaillard RC, Riondel AM, Ling N, Muller AF. 1988 Corticotropin-releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sci. 43:1935-1944.
18. Malerbi DA, Mendonca BB, Liberman B, et al. 1993 The desmopressin test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 38:463-472.
19. Trainer PJ, Faria M, Newell-Price JDC, et al. 1995 A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary adrenal axis. J Clin Endocrinol Metab. 80:412-417.
20. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB. 1993 A simplified morning ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 77:1308-1312.
21. Cunnah D, Jessop DS, Besser GM, Rees H. 1986 Measurement of circulating corticotropin-releasing factor in man. J Endocrinol. 113:123-131.
22. McLoughlin L, Evans SF, Watson JD, Hinds CJ, Rees LH. 1988 Characterisation of circulating pro-opiomelanocortin-related peptides in human septic shock. J Endocrinol. 199:159-165.
23. Gillies G, Linton EA, Lowry PJ. 1979 Corticotropin-releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 299:355-357.
24. Rivier C, Rivier J, Mormède P. 1983 Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. Endocrinology. 115:882-886.
25. Knepal W, Homolka L, Vlaskovska M, Nutto D. 1984 In vitro adrenocorticotropin/β-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity. Endocrinology. 114:1797-1804.
26. Buckingham JC. 1986 Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis. J Endocrinol. 113:389-396.
27. 1b) mRNA by adrenolectomy and glucocorticoids [Abstract P1-570]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995.
28. de Keyser Y, Lenne F, Auzan C, et al. 1995 The pituitary vasopressin receptor V3 receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest. 97:1311-1318.
29. Dahia PLM, Ahmed-Shuaib A, Jacobs RA, et al. 1996 Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumours. J Clin Endocrinolol Metab. 81:1768-1771.
30. de Keyser Y, Clauser E, Bertagna X. 1996 The pituitary V3 vasopressin receptor and the ectopic corticotropin syndrome. Curr Opin Endocrinol Diabetes. 3: 125-131.